DNA Alterations in Body Fluids as Molecular Tumor Markers for Urological Malignancies
- 1 June 2002
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 41 (6) , 668-676
- https://doi.org/10.1016/s0302-2838(02)00126-4
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using “Light-Cycler”-based quantitative real-time polymerase chain reactionUrology, 2001
- Cytokeratin–20 Reverse–Transcriptase Polymerase Chain Reaction as a New Tool for the Detection of Circulating Tumor Cells in Peripheral Blood and Bone Marrow of Bladder Cancer PatientsEuropean Urology, 2001
- Impact of Screening on Incidence and Mortality of Prostate Cancer in the United StatesEpidemiologic Reviews, 2001
- High Percentage of False-Positive Results of Cytokeratin 19 RT-PCR in Blood: A Model for the Analysis of Illegitimate Gene ExpressionOncology, 2000
- Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytesBritish Journal of Cancer, 1999
- Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): Technical and clinical aspectsInternational Journal of Cancer, 1998
- PSA screening said to reduce prostate-cancer deaths, or does it?The Lancet, 1998
- Nucleic Acid-Based Methods for the Detection of CancerScience, 1997
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991
- Illegitimate transcription: transcription of any gene in any cell type.Proceedings of the National Academy of Sciences, 1989